领航医药生物科技拟收购Conflux资产

格隆汇2025-06-30

格隆汇6月30日丨领航医药生物科技(00399.HK)宣布，于2025年6月30日，公司（作为买方）已与卖方及Conflux订立谅解备忘录，内容有关收购目标公司全部股权的潜在收购事项，前提为目标公司按照与公司的协议完成收购Conflux资产。Conflux为一间于香港注册成立的有限公司，主要从事开发区块链技术。于本公告日期，执行董事伍鸣博士亦为Conflux的董事及Conflux的唯一最终实益拥有...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2547013672?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-30 22:54","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2547013672","market":"hk","top_or_hot":-1,"title":"领航医药生物科技拟收购Conflux资产","media":"格隆汇","content":"<div>\n<p>格隆汇6月30日丨领航医药生物科技(00399.HK)宣布，于2025年6月30日，公司（作为买方）已与卖方及Conflux订立谅解备忘录，内容有关收购目标公司全部股权的潜在收购事项，前提为目标公司按照与公司的协议完成收购Conflux资产。Conflux为一间于香港注册成立的有限公司，主要从事开发区块链技术。于本公告日期，执行董事伍鸣博士亦为Conflux的董事及Conflux的唯一最终实益拥有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630225654a4c6e896&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>领航医药生物科技拟收购Conflux资产</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n领航医药生物科技拟收购Conflux资产\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-30 22:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630225654a4c6e896&s=b><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇6月30日丨领航医药生物科技(00399.HK)宣布，于2025年6月30日，公司（作为买方）已与卖方及Conflux订立谅解备忘录，内容有关收购目标公司全部股权的潜在收购事项，前提为目标公司按照与公司的协议完成收购Conflux资产。Conflux为一间于香港注册成立的有限公司，主要从事开发区块链技术。于本公告日期，执行董事伍鸣博士亦为Conflux的董事及Conflux的唯一最终实益拥有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630225654a4c6e896&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1124","symbol_name":"贸易公司与经销商","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630225654a4c6e896&s=b","article_id":"2547013672","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630225654a4c6e896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2547013672","pubTimestamp":1751295240,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"格隆汇6月30日丨领航医药生物科技宣布，于2025年6月30日，公司已与卖方及Conflux订立谅解备忘录，内容有关收购目标公司全部股权的潜在收购事项，前提为目标公司按照与公司的协议完成收购Conflux资产。Conflux为一间于香港注册成立的有限公司，主要从事开发区块链技术。于本公告日期，执行董事伍鸣博士亦为Conflux的董事及Conflux的唯一最终实益拥有人。订立谅解备忘录表明公司致力透过潜在收购事项进军数码创新行业，以发展此新业务分部。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1124":"贸易公司与经销商","00399":"星太链集团"},"translate_title":"Linghang Pharmaceutical Biotechnology plans to acquire Conflux assets","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00399":1},"content_text":"格隆汇6月30日丨领航医药生物科技(00399.HK)宣布，于2025年6月30日，公司（作为买方）已与卖方及Conflux订立谅解备忘录，内容有关收购目标公司全部股权的潜在收购事项，前提为目标公司按照与公司的协议完成收购Conflux资产。Conflux为一间于香港注册成立的有限公司，主要从事开发区块链技术。于本公告日期，执行董事伍鸣博士亦为Conflux的董事及Conflux的唯一最终实益拥有人。目标公司为一间将由卖方在开曼群岛注册成立并由卖方全资拥有的有限公司。公司正积极发掘新商机，令收益来源多元化，并实施策略计划以提升表现，且公司拟扩充业务至区块链技术，进军数码创新行业。订立谅解备忘录表明公司致力透过潜在收购事项进军数码创新行业，以发展此新业务分部。公司认为此举不但可令集团业务更多元化，亦可为集团带来新溢利增长动力。追加内容本文作者可以追加内容哦 !","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"merge","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2547013672","isCrawlerRequest":true}